Matt Scholz is a co-founder of Oisin Biotechnologies, a longevity startup that is developing a proteome-lipid nanoparticle gene therapy platform. Their lead program is a senolytic gene therapy to target senescent cells.
Kristen Fortney is the CEO and co-founder of BioAge Labs, a startup that leverages artificial intelligence and machine learning to find anti-aging drugs.